How I manage aplastic anaemia in children

British Journal of Haematology

Volumn 157, Issue 1, 2012, Pages 26-40

  Samarasinghe, Sujith ^a   Webb, David K H ^b  

^a Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Anti thymocyte globulin; Inherited bone marrow failure syndrome; Paediatric aplastic anaemia; Transplantation in aplastic anaemia

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DANAZOL; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; INFLUENZA VACCINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXYMETHOLONE; RAPAMYCIN; RITUXIMAB; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGRANULOCYTOSIS; ANAPLASTIC ANEMIA; ANEMIA; BONE MARROW BIOPSY; CHILD; CLINICAL EVALUATION; CLONAL EVOLUTION; CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DYSERYTHROPOIESIS; DYSKERATOSIS CONGENITA; ERYTHROCYTE TRANSFUSION; EVENT FREE SURVIVAL; FAILURE FREE SURVIVAL; FANCONI ANEMIA; FEBRILE NEUTROPENIA; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; INFECTION PREVENTION; INFERTILITY; IRON OVERLOAD; LOW DRUG DOSE; OVERALL SURVIVAL; PANCYTOPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENCE RISK; RETICULOCYTOPENIA; REVIEW; SCREENING; SHWACHMAN SYNDROME; SIBLING; STEM CELL NICHE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UNRELATED DONORS; WHOLE BODY RADIATION;

ADOLESCENT; ANEMIA, APLASTIC; ANIMALS; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVING DONORS; MALE; RABBITS; SIBLINGS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84858289787     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09058.x     Document Type: Review

References (100)

1. Alter, B.P., Baerlocher, G.M., Savage, S.A., Chanock, S.J., Weksler, B.B., Willner, J.P., Peters, J.A., Giri, N. & Lansdorp, P.M. (2007) Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood, 110, 1439-1447.
2. Bacigalupo, A., Locatelli, F., Lanino, E., Marsh, J., Socie, G., Maury, S., Prete, A., Locasciulli, A., Cesaro, S. & Passweg, J. (2005) Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplantation, 36, 947-950.
3. Bacigalupo, A., Socie, G., Lanino, E., Prete, A., Locatelli, F., Locasciulli, A., Cesaro, S., Shimoni, A., Marsh, J., Brune, M., Van Lint, M.T., Oneto, R. & Passweg, J. (2010) Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica, 95, 976-982.
4. Ballmaier, M. & Germeshausen, M. (2009) Advances in the understanding of congenital amegakaryocytic thrombocytopenia. British Journal of Haematology, 146, 3-16.
5. Bennett, J.M. & Orazi, A. (2009) Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach. Haematologica, 94, 264-268.
6. Bhatla, D., Davies, S.M., Shenoy, S., Harris, R.E., Crockett, M., Shoultz, L., Smolarek, T., Bleesing, J., Hansen, M., Jodele, S., Jordan, M., Filipovich, A.H. & Mehta, P.A. (2008) Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. Bone Marrow Transplantation, 42, 159-165.
7. Boocock, G.R., Morrison, J.A., Popovic, M., Richards, N., Ellis, L., Durie, P.R. & Rommens, J.M. (2003) Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nature Genetics, 33, 97-101.
8. Breatnach, F., Chessells, J.M. & Greaves, M.F. (1981) The aplastic presentation of childhood leukaemia: a feature of common-ALL. British Journal of Haematology, 49, 387-393.
9. Brodsky, R.A., Chen, A.R., Dorr, D., Fuchs, E.J., Huff, C.A., Luznik, L., Smith, B.D., Matsui, W.H., Goodman, S.N., Ambinder, R.F. & Jones, R.J. (2010) High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up. Blood, 115, 2136-2141.
10. Burroughs, L., Woolfrey, A. & Shimamura, A. (2009) Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematology/Oncology Clinics of North America, 23, 233-248.
11. Calado, R.T. & Young, N.S. (2008) Telomere maintenance and human bone marrow failure. Blood, 111, 4446-4455.
12. Camitta, B.M., Rappeport, J.M., Parkman, R. & Nathan, D.G. (1975) Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood, 45, 355-363.
13. Champlin, R., Perez, W., Passweg, J., Klein, J., Camitta, B., Gluckman, E., Bredeson, C., Eapen, M. & Horowitz, M. (2007) Bone marrow transplantation for severe apalstic anaemia: a randomized controlled study of conditioning regimens. Blood, 109, 4582-4585.
14. Crossan, G. & Patel, K. (2012) The Fanconi Anaemia Pathway Orchestrates incisions at sites of crosslinked DNA. Journal of Pathology, 226, 326-337.
15. Deeg, H.J., O'Donnell, M., Tolar, J., Agarwal, R., Harris, R.E., Feig, S.A., Territo, M.C., Collins, R.H., McSweeney, P.A., Copelan, E.A., Khan, S.P., Woolfrey, A. & Storer, B. (2006) Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood, 108, 1485-1491.
16. Dietz, A.C., Orchard, P.J., Baker, K.S., Giller, R.H., Savage, S.A., Alter, B.P. & Tolar, J. (2011) Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. Bone Marrow Transplantation, 46, 98-104.
17. Dokal, I. (2000) Dyskeratosis congenita in all its forms. British Journal Haematology, 110, 768-779.
18. Dokal, I. & Vulliamy, T. (2010) Inherited bone marrow failure syndromes. Haematologica, 95, 1236-1240.
19. Dror, Y., Ginzberg, H., Dalal, I., Cherepanov, V., Downey, G., Durie, P., Roifman, C.M. & Freedman, M.H. (2001) Immune function in patients with Shwachman-Diamond syndrome. British Journal Haematology, 114, 712-717.
20. Dufour, C., Rondelli, R., Locatelli, F., Miano, M., Di Girolamo, G., Bacigalupo, A., Messina, C., Porta, F., Balduzzi, A., Iorio, A.P., Buket, E., Madon, E., Pession, A., Dini, G. & Di Bartolomeo, P. (2001) Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO. British Journal Haematology, 112, 796-805.
21. Eapen, M. & Horowitz, M.M. (2010) Alternative donor transplantation for aplastic anemia. Hematology American Society of Hematology Education Program, 2010, 43-46.
22. Eapen, M., Le Rademacher, J., Antin, J.H., Champlin, R.E., Carreras, J., Fay, J., Passweg, J.R., Tolar, J., Horowitz, M.M., Marsh, J.C. & Deeg, H.J. (2011) Effect of stem cell source on outcomes after adult unrelated donor transplantation in severe aplastic anemia. Blood, 118, 2618-2621.
23. European Blood and Marrow Transplant Group, Severe Aplastic Anaemia Working Party (2011) Rabbit ATG for aplastic anaemia treatment: a backward step? Lancet, 378, 1831-1833.
24. Farzin, A., Davies, S.M., Smith, F.O., Filipovich, A., Hansen, M., Auerbach, A.D. & Harris, R.E. (2007) Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience. British Journal Haematology, 136, 633-640.
25. Filipovich, A.H., Zhang, K., Snow, A.L. & Marsh, R.A. (2010) X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood, 116, 3398-3408.
26. Fogarty, P.F., Yamaguchi, H., Wiestner, A., Baerlocher, G.M., Sloand, E., Zeng, W.S., Read, E.J., Lansdorp, P.M. & Young, N.S. (2003) Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet, 362, 1628-1630.
27. Frickhofen, N., Heimpel, H., Kaltwasser, J.P. & Schrezenmeier, H. (2003) Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood, 101, 1236-1242.
28. de la Fuente, J., Reiss, S., McCloy, M., Vulliamy, T., Roberts, I., Rahemtulla, A. & Dokal, I. (2003) Non-TBI stem cell transplantation protocol for Fanconi anamia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplantation, 32, 653-656.
29. Fuhrer, M., Rampf, U., Baumann, I., Faldum, A., Niemeyer, C., Janka-Schaub, G., Friedrich, W., Ebell, W., Borkhardt, A. & Bender-Goetze, C. (2005) Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood, 106, 2102-2104.
30. Gluckman, E., Berger, R. & Dutreix, J. (1984) Bone marrow transplantation for Fanconi anemia. Seminars in Hematology, 21, 20-26.
31. Gluckman, E., Rocha, V., Ionescu, I., Bierings, M., Harris, R.E., Wagner, J., Kurtzberg, J., Champagne, M.A., Bonfim, C., Bittencourt, M., Darbyshire, P., Fernandez, M.N., Locatelli, F. & Pasquini, R. (2007) Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. Biology of Blood and Marrow Transplantation, 13, 1073-1082.
32. Guardiola, P., Socie, G., Li, X., Ribaud, P., Devergie, A., Esperou, H., Richard, P., Traineau, R., Janin, A. & Gluckman, E. (2004) Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood, 103, 73-77.
33. Gupta, V., Ball, S.E., Yi, Q.L., Sage, D., McCann, S.R., Lawler, M., Ortin, M., Freires, M., Hale, G., Waldmann, H., Gordon-Smith, E.C. & Marsh, J.C. (2004) Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Biology of Blood and Marrow Transplantation, 10, 867-876.
34. Gupta, V., Gordon-Smith, E.C., Cook, G., Parker, A., Duguid, J.K., Wilson, K.M., Yi, Q.L. & Marsh, J.C. (2005) A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders. British Journal Haematology, 129, 110-117.
35. Hendry, C.L., Sivakumaran, M., Marsh, J.C. & Gordon-Smith, E.C. (2002) Relapse of severe aplastic anaemia after influenza immunization. British Journal Haematology, 119, 283-284.
36. Ihara, K., Ishii, E., Eguchi, M., Takada, H., Suminoe, A., Good, R.A. & Hara, T. (1999) Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proceedings of the National Academy of Sciences of the United States of America, 96, 3132-3136.
37. Kahl, C., Leisenring, W., Deeg, H.J., Chauncey, T.R., Flowers, M.E., Martin, P.J., Sanders, J.E. & Storb, R. (2005) Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. British Journal Haematology, 130, 747-751.
38. Kamio, T., Ito, E., Ohara, A., Kosaka, Y., Tsuchida, M., Yagasaki, H., Mugishima, H., Yabe, H., Morimoto, A., Ohga, S., Muramatsu, H., Hama, A., Kaneko, T., Nagasawa, M., Kikuta, A., Osugi, Y., Bessho, F., Nakahata, T., Tsukimoto, I. & Kojima, S. (2011) Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group. Haematologica, 96, 814-819.
39. Kennedy-Nasser, A.A., Leung, K.S., Mahajan, A., Weiss, H.L., Arce, J.A., Gottschalk, S., Carrum, G., Khan, S.P., Heslop, H.E., Brenner, M.K., Bollard, C.M. & Krance, R.A. (2006) Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biology of Blood and Marrow Transplantation, 12, 1277-1284.
40. Knudson, M., Kulkarni, S., Ballas, Z.K., Bessler, M. & Goldman, F. (2005) Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. Blood, 105, 682-688.
41. Kobayashi, R., Yabe, H., Hara, J., Morimoto, A., Tsuchida, M., Mugishima, H., Ohara, A., Tsukimoto, I., Kato, K., Kigasawa, H., Tabuchi, K., Nakahata, T., Ohga, S. & Kojima, S. (2006) Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings. British Journal Haematology, 135, 693-696.
42. Kojima, S., Horibe, K., Inaba, J., Yoshimi, A., Takahashi, Y., Kudo, K., Kato, K. & Matsuyama, T. (2000) Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation. British Journal Haematology, 111, 321-328.
43. Kojima, S., Nakao, S., Young, N., Bacigalupo, A., Gerard, G., Hirano, N., Maciejewski, J., Deeg, J., Marsh, J., Zhang, F.K., Lee, J.W. & Ozawa, K. (2011) The Third Consensus Conference on the treatment of aplastic anemia. International Journal of Hematology, 93, 832-837.
44. Kosaka, Y., Yagasaki, H., Sano, K., Kobayashi, R., Ayukawa, H., Kaneko, T., Yabe, H., Tsuchida, M., Mugishima, H., Ohara, A., Morimoto, A., Otsuka, Y., Ohga, S., Bessho, F., Nakahata, T., Tsukimoto, I. & Kojima, S. (2008) Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia. Blood, 111, 1054-1059.
45. Kutler, D.I., Singh, B., Satagopan, J., Batish, S.D., Berwick, M., Giampietro, P.F., Hanenberg, H. & Auerbach, A.D. (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood, 101, 1249-1256.
46. Lawler, M., McCann, S.R., Marsh, J.C., Ljungman, P., Hows, J., Vandenberghe, E., O'Riordan, J., Locasciulli, A., Socie, G., Kelly, A., Schrezenmeier, H., Marin, P., Tichelli, A., Passweg, J.R., Dickenson, A., Ryan, J. & Bacigalupo, A. (2009) Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA. British Journal of Haematology, 144, 933-945.
47. Lee, J.W., Yoon, S.S., Shen, Z.X., Ganser, A., Hsu, H.C., Habr, D., Domokos, G., Roubert, B. & Porter, J.B. (2010) Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial. Blood, 116, 2448-2454.
48. Lo Ten Foe, J.R., Kwee, M.L., Rooimans, M.A., Oostra, A.B., Veerman, A.J., van Weel, M., Pauli, R.M., Shahidi, N.T., Dokal, I., Roberts, I., Altay, C., Gluckman, E., Gibson, R.A., Mathew, C.G., Arwert, F. & Joenje, H. (1997) Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. European Journal of Human Genetics, 5, 137-148.
49. Locatelli, F., Bruno, B., Zecca, M., Van-Lint, M.T., McCann, S., Arcese, W., Dallorso, S., Di Bartolomeo, P., Fagioli, F., Locasciulli, A., Lawler, M. & Bacigalupo, A. (2000) Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood, 96, 1690-1697.
50. MacMillan, M.L. & Wagner, J.E. (2010) Haematopoeitic cell transplantation for Fanconi anaemia - when and how? British Journal of Haematology, 149, 14-21.
51. Marsh, J.C., Ball, S.E., Cavenagh, J., Darbyshire, P., Dokal, I., Gordon-Smith, E.C., Keidan, J., Laurie, A., Martin, A., Mercieca, J., Killick, S.B., Stewart, R. & Yin, J.A. (2009) Guidelines for the diagnosis and management of aplastic anaemia. British Journal Haematology, 147, 43-70.
52. Marsh, J., Socie, G., Tichelli, A., Schrezenmeier, H., Hochsmann, B., Risitano, A.M., Fuehrer, M., Bekassy, A.N., Korthof, E.T., Locasciulli, A., Ljungman, P., Bacigalupo, A., Camitta, B., Young, N.S. & Passweg, J. (2010) Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. British Journal Haematology, 150, 377-379.
53. Marsh, J.C., Gupta, V., Lim, Z., Ho, A.Y., Ireland, R.M., Hayden, J., Potter, V., Koh, M.B., Islam, M.S., Russell, N., Marks, D.I., Mufti, G.J. & Pagliuca, A. (2011) Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. Blood, 118, 2351-2357.
54. Maury, S., Balere-Appert, M.L., Chir, Z., Boiron, J.M., Galambrun, C., Yakouben, K., Bordigoni, P., Marie-Cardine, A., Milpied, N., Kanold, J., Maillard, N. & Socie, G. (2007) Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica, 92, 589-596.
55. McCann, S., Passweg, J., Bacigalupo, A., Locasciulli, A., Locatelli, F., Ryan, J., Schrezenmeier, H. & Lawler, M. (2007) The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia. Bone Marrow Transplantation, 39, 109-114.
56. Montane, E., Ibanez, L., Vidal, X., Ballarin, E., Puig, R., Garcia, N. & Laporte, J.R. (2008) Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica, 93, 518-523.
57. Niederwieser, D., Pepe, M., Storb, R., Loughran, Jr, T.P. & Longton, G. (1988) Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia. British Journal of Haematology, 69, 23-28.
58. Pasquini, R., Carreras, J., Pasquini, M.C., Camitta, B.M., Fasth, A.L., Hale, G.A., Harris, R.E., Marsh, J.C., Robinson, A.J., Zhang, M.J., Eapen, M. & Wagner, J.E. (2008) HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biology of Blood and Marrow Transplantation, 14, 1141-1147.
59. Passweg, J.R. & Marsh, J.C. (2010) Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation. Hematology American Society of Hematology Education Program, 2010, 36-42.
60. Passweg, J.R. & Tichelli, A. (2009) Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling? Haematologica, 94, 310-312.
61. Peffault de Latour, R., Purtill, D., Ruggeri, A., Sanz, G., Michel, G., Gandemer, V., Maury, S., Kurtzberg, J., Bonfim, C., Aljurf, M., Gluckman, E., Socie, G., Passweg, J. & Rocha, V. (2011) Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Biology of Blood and Marrow Transplantation, 17, 78-85.
62. Perez-Albuerne, E.D., Eapen, M., Klein, J., Gross, T.J., Lipton, J.M., Baker, K.S., Woolfrey, A. & Kamani, N. (2008) Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. British Journal of Haematology, 141, 216-223.
63. Resnick, I., Aker, M., Shapira, M., Tsirigotis, P., Bitan, M., Abdul-Hai, A., Samuel, S., Ackerstein, A., Gesundheit, B., Zilberman, I., Miron, S., Yoffe, L., Lvovich, A., Salvin, S. & Or, R. (2006) Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen. British Journal of Haematology, 133, 649-654.
64. Risitano, A.M., Selleri, C., Serio, B., Torelli, G.F., Kulagin, A., Maury, S., Halter, J., Gupta, V., Bacigalupo, A., Socie, G., Tichelli, A., Schrezenmeier, H., Marsh, J., Passweg, J. & Rotoli, B. (2010) Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA. British Journal of Haematology, 148, 791-796.
65. Rosenberg, P.S., Alter, B.P., Bolyard, A.A., Bonilla, M.A., Boxer, L.A., Cham, B., Fier, C., Freedman, M., Kannourakis, G., Kinsey, S., Schwinzer, B., Zeidler, C., Welte, K. & Dale, D.C. (2006) The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood, 107, 4628-4635.
66. Roth, A. & Duhrsen, U. (2011) Treatment of Paroxysmal Nocturnal Hemoglobinuria in the Era of Eculizumab. European Journal of Haematology, 87, 473-579.
67. Samarasinghe, S., Steward, C., Hiwarkar, P., Saif, M.A., Hough, R., Webb, D., Norton, A., Lawson, S., Qureshi, A., Connor, P., Carey, P., Skinner, R., Vora, A., Pelidis, M., Gibson, B., Stewart, G., Keogh, S., Goulden, N., Bonney, D., Stubbs, M., Amrolia, P., Rao, K., Meyer, S., Wynn, R. & Veys, P. (2012) Excellent Outcome of Matched Unrelated Donor Transplantation in Paediatric Aplastic Anaemia following Failure with Immunosuppressive Therapy: a United Kingdom Retrospective Multicentre Experience. British Journal of Haematology, (in press).
68. Sanders, J.E., Woolfrey, A.E., Carpenter, P.A., Storer, B.E., Hoffmeister, P.A., Deeg, H.J., Flowers, M.E. & Storb, R.F. (2011) Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood, 118, 1421-1428.
69. Saracco, P., Quarello, P., Iori, A.P., Zecca, M., Longoni, D., Svahn, J., Varotto, S., Del Vecchio, G.C., Dufour, C., Ramenghi, U., Bacigalupo, A. & Locasciulli, A. (2008) Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up. British Journal Haematology, 140, 197-205.
70. Scheinberg, P., Nunez, O., Wu, C. & Young, N.S. (2006a) Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. British Journal Haematology, 133, 606-611.
71. Scheinberg, P., Nunez, O. & Young, N.S. (2006b) Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. British Journal Haematology, 133, 622-627.
72. Scheinberg, P., Wu, C.O., Nunez, O. & Young, N.S. (2008) Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. Journal of Pediatrics, 153, 814-819.
73. Scheinberg, P., Wu, C.O., Nunez, O., Boss, C., Sloand, E.M. & Young, N.S. (2009) Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica, 94, 348-354.
74. Scheinberg, P., Nunez, O., Scheinberg, P. & Young, N. (2011a) Cyclosporin Taper does not Prevent Relapse in Severe Aplastic Anaemia. Blood (Annual ASH Meeting Abstracts), 118, 2406.
75. Scheinberg, P., Nunez, O., Weinstein, B., Biancotto, A., Wu, C.O. & Young, N.S. (2011b) Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. New England Journal of Medicine, 365, 430-438.
76. Schrezenmeier, H., Passweg, J.R., Marsh, J.C., Bacigalupo, A., Bredeson, C.N., Bullorsky, E., Camitta, B.M., Champlin, R.E., Gale, R.P., Fuhrer, M., Klein, J.P., Locasciulli, A., Oneto, R., Schattenberg, A.V., Socie, G. & Eapen, M. (2007) Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood, 110, 1397-1400.
77. Shaw, B.E., Apperley, J.F., Russell, N.H., Craddock, C., Liakopoulou, E., Potter, M.N., Wynn, R., Gibson, B., Pearce, R.M., Kirkland, K., Lee, J., Madrigal, J.A., Cook, G. & Byrne, J.L. (2011) Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. British Journal Haematology, 153, 244-252.
78. Shimamura, A. & Alter, B.P. (2010) Pathophysiology and management of inherited bone marrow failure syndromes. Blood Reviews, 24, 101-122.
79. Skinner, R., Cant, A., Davies, G., Finn, A. & Foot, A. (2002)Immunisation of the Immunocompromised child. Best Practice Statement. Royal College of Paediatrics and Child Health, London.
80. Smith, O.P., Hann, I.M., Chessells, J.M., Reeves, B.R. & Milla, P. (1996) Haematological abnormalities in Shwachman-Diamond syndrome. British Journal Haematology, 94, 279-284.
81. Socie, G., Henry-Amar, M., Bacigalupo, A., Hows, J., Tichelli, A., Ljungman, P., McCann, S.R., Frickhofen, N., Van't Veer-Korthof, E. & Gluckman, E. (1993) Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. New England Journal of Medicine, 329, 1152-1157.
82. Socie, G., Mary, J.Y., Schrezenmeier, H., Marsh, J., Bacigalupo, A., Locasciulli, A., Fuehrer, M., Bekassy, A., Tichelli, A. & Passweg, J. (2007) Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT). Blood, 109, 2794-2796.
83. Stern, M., Passweg, J.R., Locasciulli, A., Socie, G., Schrezenmeier, H., Bekassy, A.N., Fuehrer, M., Hows, J., Korthof, E.T., McCann, S., Tichelli, A., Zoumbos, N.C., Marsh, J.C., Bacigalupo, A. & Gratwohl, A. (2006) Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation, 82, 218-226.
84. Storb, R., Prentice, R.L., Sullivan, K.M., Shulman, H.M., Deeg, H.J., Doney, K.C., Buckner, C.D., Clift, R.A., Witherspoon, R.P., Appelbaum, F.A., Sanders, J.E., Stewart, P.S. & Thomas, E.D. (1983) Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Annals of Internal Medicine, 98, 461-466.
85. Storb, R., Deeg, V., Farewell, K., Doney, F., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C. & Clift, R. (1986) Marrow transplantation for severe aplastic anaemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of graft-versus-host disease. Blood, 68, 119-125.
86. Takanashi, M., Atsuta, Y., Fujiwara, K., Kodo, H., Kai, S., Sato, H., Kohsaki, M., Azuma, H., Tanaka, H., Ogawa, A., Nakajima, K. & Kato, S. (2010) The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood, 116, 2839-2846.
87. Tarek, N., Kernan, N.A., Prockop, S.E., Scaradavou, A., Small, T.N., O'Reilly, R.J. & Boulad, F. (2011) T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia. Bone Marrow Transplantation, 1-3. doi:10.1038/bmt.2011.142.
88. Tichelli, A., Passweg, J., Nissen, C., Bargetzi, M., Hoffmann, T., Wodnar-Filipowicz, A., Signer, E., Speck, B. & Gratwohl, A. (1998) Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia. British Journal Haematology, 100, 393-400.
89. Tichelli, A., Schrezenmeier, H., Socie, G., Marsh, J., Bacigalupo, A., Duhrsen, U., Franzke, A., Hallek, M., Thiel, E., Wilhelm, M., Hochsmann, B., Barrois, A., Champion, K. & Passweg, J.R. (2011) A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. Blood, 117, 4434-4441.
90. Viollier, R., Socie, G., Tichelli, A., Bacigalupo, A., Korthof, E.T., Marsh, J., Cornish, J., Ljungman, P., Oneto, R., Bekassy, A.N., Fuehrer, M., Maury, S., Schrezenmeier, H., van Lint, M.T., Wojcik, D., Locasciulli, A. & Passweg, J.R. (2008) Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplantation, 41, 45-50.
91. Vulliamy, T.J., Marrone, A., Knight, S.W., Walne, A., Mason, P.J. & Dokal, I. (2006) Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood, 107, 2680-2685.
92. Wagner, J.E., Eapen, M., MacMillan, M.L., Harris, R.E., Pasquini, R., Boulad, F., Zhang, M.J. & Auerbach, A.D. (2007) Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood, 109, 2256-2262.
93. Walne, A.J. & Dokal, I. (2009) Advances in the understanding of dyskeratosis congenita. British Journal Haematology, 145, 164-172.
94. Walne, A.J., Vulliamy, T., Beswick, R., Kirwan, M. & Dokal, I. (2010) Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, pokiloderma with neutropenia and Rothmund-Thomson syndrome. Human Molecular Genetics, 19, 4453-4461.
95. Yagasaki, H., Kojima, S., Yabe, H., Kato, K., Kigasawa, H., Sakamaki, H., Tsuchida, M., Kato, S., Kawase, T., Morishima, Y. & Kodera, Y. (2011) Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia. Blood, 118, 3186-3190.
96. Yamamoto, H., Kato, D., Uchida, N., Ishiwata, K., Araoka, H., Takagi, S., Nakano, N., Tsuji, M., Asano-Mori, Y., Matsuno, N., Masuoka, K., Izutsu, K., Wake, A., Yoneyama, A., Makino, S. & Taniguchi, S. (2011) Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia. Blood, 117, 3240-3242.
97. Yoshida, N., Yagasaki, H., Hama, A., Takahashi, Y., Kosaka, Y., Kobayashi, R., Yabe, H., Kaneko, T., Tsuchida, M., Ohara, A., Nakahata, T. & Kojima, S. (2011) Predicting response to immunosuppressive therapy in childhood aplastic anemia. Haematologica, 96, 771-774.
98. Yoshimi, A., Kojima, S., Taniguchi, S., Hara, J., Matsui, T., Takahashi, Y., Azuma, H., Kato, K., Nagamura-Inoue, T., Kai, S. & Kato, S. (2008) Unrelated cord blood transplantation for severe aplastic anemia. Biology of Blood and Marrow Transplantation, 14, 1057-1063.
99. Young, N.S., Bacigalupo, A. & Marsh, J.C. (2010) Aplastic anemia: pathophysiology and treatment. Biology of Blood and Marrow Transplantation, 16, S119-S125.
100. Zhong, F., Savage, S., Shrekli, M., Giri, N., Jessop, L., Myers, T., Chen, R., Alter, B. & Artandi, S. (2011) Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes and Development, 25, 11-16.